首页> 外文期刊>Breast Cancer Research >26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on preclinical and translational research
【24h】

26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on preclinical and translational research

机译:第26届年度圣安东尼奥乳腺癌研讨会,2003年12月3日至6日,美国德克萨斯州圣安东尼奥:临床前和转化研究的最新进展

获取原文
       

摘要

The San Antonio Breast Cancer Symposium is the largest annual meeting devoted solely to breast cancer research. The late William L McGuire's vision for this meeting was to stimulate 'translational research', many years before this term became popular. In this way, the San Antonio Breast Cancer Symposium represents a forum in which basic and clinical researchers present their research side by side. Each year sees the continued evolution of our understanding of the basic mechanisms of breast cancer initiation and progression, and the clinical application of this knowledge. Major topics of discussion at the symposium this year were the cell cycle, new evolving concepts of estrogen receptor action, breast cancer stem cells, new predictive and prognostic markers (including microarray studies), and continued exploration of the mechanisms of drug resistance. This report will summarize preclinical and translational highlights from the meeting.Keywords: BRCA1, cell cycle, drug resistance, estrogen receptor, growth factor receptors, microarray, prognostic and predictive markers
机译:圣安东尼奥乳腺癌专题讨论会是最大的年度会议,专门讨论乳腺癌研究。已故威廉·麦奎尔(William L McGuire)的这次会议的愿景是激发“翻译研究”,这一术语流行了很多年。这样,圣安东尼奥乳腺癌专题讨论会就是一个论坛,基础和临床研究人员在此论坛上并行介绍了他们的研究。每年,我们对乳腺癌的发生和发展的基本机制以及这种知识在临床上的应用的理解都在不断发展。今年研讨会上讨论的主要主题是细胞周期,雌激素受体作用的新发展概念,乳腺癌干细胞,新的预测和预后标志物(包括微阵列研究)以及对耐药机制的不断探索。关键字:BRCA1,细胞周期,耐药性,雌激素受体,生长因子受体,微阵列,预后和预测标志物

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号